Header cover image

U.K. (FTSE) Healthcare Sector Analysis

UpdatedDec 03, 2023
DataAggregated Company Financials
Companies118
  • 7D0.2%
  • 3M-2.7%
  • 1Y-6.2%
  • YTD-8.6%

In the last week, the Healthcare industry is flat overall, with Genus standing out by going down 8.7%. As for the longer term, the industry has declined 6.2% in the last year. As for the next few years, earnings are expected to grow by 18% per annum.

Sector Valuation and Performance

Has the U.K. Healthcare Sector valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Sun, 03 Dec 2023UK£261.8bUK£84.0bUK£10.7b39x24.6x3.1x
Tue, 31 Oct 2023UK£263.7bUK£86.0bUK£10.3b40.1x25.6x3.1x
Thu, 28 Sep 2023UK£282.3bUK£86.2bUK£10.3b39.9x27.3x3.3x
Sat, 26 Aug 2023UK£270.2bUK£84.5bUK£10.2b40.4x26.5x3.2x
Mon, 24 Jul 2023UK£273.7bUK£82.1bUK£7.8b46.6x34.9x3.3x
Wed, 21 Jun 2023UK£285.0bUK£82.4bUK£7.9b46.9x36.2x3.5x
Fri, 19 May 2023UK£293.7bUK£83.6bUK£8.0b46.7x36.8x3.5x
Sun, 16 Apr 2023UK£295.7bUK£84.3bUK£6.9b46.4x42.8x3.5x
Tue, 14 Mar 2023UK£268.8bUK£85.1bUK£6.9b41.3x38.8x3.2x
Thu, 09 Feb 2023UK£278.7bUK£86.0bUK£6.6b36.8x42.3x3.2x
Sat, 07 Jan 2023UK£291.4bUK£95.3bUK£6.6b36.5x44.1x3.1x
Mon, 05 Dec 2022UK£280.6bUK£94.6bUK£6.6b36.9x42.6x3x
Wed, 02 Nov 2022UK£266.0bUK£95.5bUK£4.0b30.2x66.4x2.8x
Fri, 30 Sep 2022UK£252.8bUK£97.4bUK£4.0b27.9x63.4x2.6x
Sun, 28 Aug 2022UK£281.3bUK£93.9bUK£4.1b35.4x68.7x3x
Tue, 26 Jul 2022UK£288.9bUK£89.9bUK£4.9b33.2x58.7x3.2x
Thu, 23 Jun 2022UK£294.6bUK£88.9bUK£5.0b34.8x59.3x3.3x
Sat, 21 May 2022UK£302.3bUK£88.2bUK£5.0b28.1x60.6x3.4x
Mon, 18 Apr 2022UK£308.8bUK£81.2bUK£5.1b35.8x60.4x3.8x
Wed, 16 Mar 2022UK£279.6bUK£81.2bUK£5.1b31.2x55.2x3.4x
Fri, 11 Feb 2022UK£276.3bUK£75.9bUK£6.1b32.9x45.4x3.6x
Sun, 09 Jan 2022UK£277.2bUK£75.3bUK£6.0b31.9x46x3.7x
Tue, 07 Dec 2021UK£274.2bUK£76.0bUK£6.1b30.4x45x3.6x
Thu, 04 Nov 2021UK£294.3bUK£72.5bUK£7.7b30.1x38x4.1x
Sat, 02 Oct 2021UK£270.7bUK£72.3bUK£7.9b32.8x34.4x3.7x
Mon, 30 Aug 2021UK£274.5bUK£71.4bUK£7.9b33.7x35x3.8x
Tue, 06 Jul 2021UK£251.2bUK£71.2bUK£7.8b37.9x32.2x3.5x
Fri, 09 Apr 2021UK£217.4bUK£68.8bUK£8.7b33x25x3.2x
Thu, 31 Dec 2020UK£219.9bUK£69.8bUK£8.1b43.6x27.1x3.2x
Price to Earnings Ratio

27.2x


Total Market Cap: UK£224.7bTotal Earnings: UK£8.3bTotal Revenue: UK£70.4bTotal Market Cap vs Earnings and Revenue0%0%0%
U.K. Healthcare Sector Price to Earnings3Y Average 43.4x202120222023
Current Industry PE
  • Investors are pessimistic on the British Healthcare industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The industry is trading at a PE ratio of 24.6x which is lower than its 3-year average PE of 43.4x.
  • The industry is trading close to its 3-year average PS ratio of 3.4x.
Past Earnings Growth
  • The earnings for companies in the Healthcare industry have grown 8.9% per year over the last three years.
  • Revenues for these companies have grown 6.0% per year.
  • This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.

Industry Trends

Which industries have driven the changes within the U.K. Healthcare sector?

GB Market0.38%
Healthcare0.20%
Life Sciences1.75%
Healthtech0.34%
Pharma0.32%
Medical Equipment0.26%
Healthcare Services-0.41%
Biotech-4.40%
Industry PE
  • Investors are most optimistic about the Medical Equipment industry which is trading above its 3-year average PE ratio of 82.3x.
    • Analysts are expecting annual earnings growth of 27.2%, which is higher than its past year's earnings decline of 12.2% per year.
Forecasted Growth
  • Analysts are most optimistic on the Medical Equipment industry, expecting annual earnings growth of 27% over the next 5 years.
  • This is better than its past earnings decline of 12% per year.
  • In contrast, the Healthtech industry is expected to see its earnings grow by 15% per year over the next few years.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
GSK GSKUK£14.360.9%
+UK£830.9m
0.8%PE9.6x
AZN AstraZenecaUK£101.980.2%
+UK£280.2m
-8.8%PE34.1x
SN. Smith & NephewUK£10.361.1%
+UK£95.7m
-5.0%PE52.7x
ONT Oxford Nanopore TechnologiesUK£1.931.8%
+UK£30.7m
-29.8%PS10.2x
TSTL TristelUK£4.608.9%
+UK£17.8m
27.8%PE48.9x
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

HCM

UK£2.90

HUTCHMED (China)

7D

-3.3%

1Y

28.0%

AZN

UK£101.98

AstraZeneca

7D

0.2%

1Y

-8.8%

GSK

UK£14.36

GSK

7D

0.9%

1Y

0.8%

GNS

UK£19.09

Genus

7D

-8.7%

1Y

-36.8%

INDV

UK£13.00

Indivior

7D

-0.6%

1Y

-24.4%

TSTL

UK£4.60

Tristel

7D

8.9%

1Y

27.8%

ERGO

UK£13.46

Ergomed

7D

0.1%

1Y

3.5%

CTEC

UK£2.26

ConvaTec Group

7D

-1.1%

1Y

-2.9%

PRTC

UK£1.52

PureTech Health

7D

-6.2%

1Y

-48.3%

ONT

UK£1.93

Oxford Nanopore Technologies

7D

1.8%

1Y

-29.8%

EMIS

UK£19.20

EMIS Group

7D

0.1%

1Y

2.8%

AVCT

UK£1.35

Avacta Group

7D

-3.6%

1Y

26.2%